{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:53:11Z","timestamp":1791244391530,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nmd.2026.107400","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:41:15Z","timestamp":1787701275000},"page":"107400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Noninfectious meningitis related to nusinersen: a pharmacovigilance analysis using the WHO database"],"prefix":"10.1016","volume":"67","author":[{"given":"Leonie","family":"Kriz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Kana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0195-0115","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Bonzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7\u20138","key":"10.1016\/j.nmd.2026.107400_bib0001","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neurol.2019.07.005","article-title":"Aseptic meningitis","volume":"175","author":"Tattevin","year":"2019","journal-title":"Rev Neurol"},{"issue":"3","key":"10.1016\/j.nmd.2026.107400_bib0002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/QCO.0000000000001105","article-title":"Aseptic meningitis: a foundation review","volume":"38","author":"Allos","year":"2025","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.nmd.2026.107400_bib0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/WNF.0000000000000667","article-title":"Drug-induced aseptic meningitis: a 25-year systematic review of case reports","volume":"49","author":"Singh","year":"2026","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"10.1016\/j.nmd.2026.107400_bib0004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/fcp.12349","article-title":"Drug-induced aseptic meningitis: a mini-review","volume":"32","author":"Yelehe-Okouma","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.nmd.2026.107400_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2025.105365","article-title":"Aseptic meningoencephalitis during nusinersen therapy in a patient with type III spinal muscular atrophy: a case report","volume":"50","author":"Kolakowski","year":"2025","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2026.107400_bib0006","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1002\/mus.27042","article-title":"Possible recurrent aseptic meningitis associated with nusinersen therapy","volume":"62","author":"Moshe-Lilie","year":"2020","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.nmd.2026.107400_bib0007","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.107400_bib0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/TACG.S239603","article-title":"Spinal muscular atrophy: mutations, testing, and clinical relevance","volume":"Volume 14","author":"Keinath","year":"2021","journal-title":"Appl Clin Genet"},{"issue":"1","key":"10.1016\/j.nmd.2026.107400_bib0009","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12887-022-03671-x","article-title":"Advances and limitations for the treatment of spinal muscular atrophy","volume":"22","author":"Day","year":"2022","journal-title":"BMC Pediatr"},{"issue":"15_supplement","key":"10.1016\/j.nmd.2026.107400_bib0010","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1212\/WNL.94.15_supplement.2528","article-title":"SMA patient experienced aseptic meningitis with severe hypoglycorrhachia after Nusinersen infusion (2528)","volume":"94","author":"Janarious","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2026.107400_bib0011","unstructured":"VigiBase, retrieved 2025 from: https:\/\/www.who-umc.org\/ [Internet]."},{"key":"10.1016\/j.nmd.2026.107400_bib0012","article-title":"Important medical event terms list (MedDRA version 28.1) [Internet]","year":"2025","journal-title":"Int Counc Harmon"},{"issue":"3","key":"10.1016\/j.nmd.2026.107400_bib0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00002018-200022030-00005","article-title":"Drug-induced aseptic meningitis: diagnosis and management","volume":"22","author":"Jolles","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.nmd.2026.107400_bib0014","unstructured":"Drugs that cause aseptic meningitis [Internet]. 2024. Available from: https:\/\/www.micromedexsolutions.com\/."},{"issue":"11","key":"10.1016\/j.nmd.2026.107400_bib0015","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/bcp.14073","article-title":"Drug-induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis","volume":"85","author":"Bihan","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.nmd.2026.107400_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.166063","article-title":"Spinal muscular atrophy: broad disease spectrum and sex-specific phenotypes","volume":"1867","author":"Singh","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"12","key":"10.1016\/j.nmd.2026.107400_bib0017","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1016\/j.jaip.2023.09.031","article-title":"Drug allergy in women","volume":"11","author":"Lee","year":"2023","journal-title":"J Allergy Clin Immunol Pr"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626010680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626010680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:01:25Z","timestamp":1791241285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896626010680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"alternative-id":["S0960896626010680"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2026.107400","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninfectious meningitis related to nusinersen: a pharmacovigilance analysis using the WHO database","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2026.107400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107400"}}